Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

U.S. Stem Cell Inc (USRM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Stem Cells Shows Promise For Repairing Torn Meniscus

USRM : 0.0289 (+2.85%)
Stem Cells Shows Promise For Repairing Torn Meniscus

U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced it has demonstrated successful,...

USRM : 0.0289 (+2.85%)
'Renewing Our Heroes' to Provide USRM Stem Cell Protocol to First Responders

U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced Renewing Our Heroes -- a charitable...

USRM : 0.0289 (+2.85%)
USRM Chief Science Officer to Present at Fifth Annual Cell Surgical World Conference

U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer, Dr....

USRM : 0.0289 (+2.85%)
World Bodybuilding Expert Interviews USRM Chief Science Officer At Paleo F(X) Conference

U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced the release of USRM Chief Science...

USRM : 0.0289 (+2.85%)
USRM Chief Science Officer, Dr. Kristin Comella, Featured on Health Boot Camps' Webinar

U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer,...

USRM : 0.0289 (+2.85%)
U.S. Department of Justice Files Lawsuit at Request of FDA to Stop U.S. Stem Cell Clinic from Performing Autologous Stem Cell Procedure

SUNRISE, Fla. , May 9, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (OTC: USRM), a world leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine...

USRM : 0.0289 (+2.85%)
U.S. Stem Cell Reports First Quarter Results

SUNRISE, Fla. , May 9, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions,...

USRM : 0.0289 (+2.85%)
U.S. Stem Cell Reports First Quarter Results

U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced first quarter results for 2018....

USRM : 0.0289 (+2.85%)
USRM Chief Science Officer to Host Webinar on Autologous Stem Cell Therapy

U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer, Dr....

USRM : 0.0289 (+2.85%)
USRM Chief Science Officer Featured in Live Interview for Biohacker Summit in Helsinki

MIAMI , May 3, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, announced...

USRM : 0.0289 (+2.85%)
Market Demand for Stem Cell Treatments Driving Steady Increase in USRM Sales

U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced sales figures for 2016 and 2017...

USRM : 0.0289 (+2.85%)
USRM Announces 2017 Financial Results

U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today filed a Form 10-K reporting year-end numbers...

USRM : 0.0289 (+2.85%)
Newest Clinic Opens Today at The Villages in Central Florida

U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced the opening its first USRM clinic...

USRM : 0.0289 (+2.85%)
USRM Demonstrates 99% Reduction in Severity of Psoriasis Utilizing Autologous Stem Cells

U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced it has published in the scientific...

USRM : 0.0289 (+2.85%)
USRM Demonstrates 99% Reduction in Severity of Psoriasis Utilizing Autologous Stem Cells

SUNRISE, Fla. , March 21, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions,...

USRM : 0.0289 (+2.85%)
USRM Chief Science Officer to Present at Paleo f(x) Ancestral Healing Conference in Austin, Texas

SUNRISE, Fla. , March 20, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions,...

USRM : 0.0289 (+2.85%)
USRM Chief Science Officer to Present at Paleo f(x) Ancestral Healing Conference in Austin, Texas

U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, is pleased to announce its Chief Science Officer,...

USRM : 0.0289 (+2.85%)
New Research: Key Drivers of Growth for Bioheart and Elite Pharmaceuticals - Factors of Influence, Major Initiatives and Sustained Production

NEW YORK, NY / ACCESSWIRE / March 7, 2018 / Latest key findings by Growth Market Report for all traders, shareholders, and investors of Bioheart Inc. (OTCQB: USRM) and Elite Pharmaceuticals Inc. (OTCQB:...

ELTP : 0.1030 (-0.29%)
USRM : 0.0289 (+2.85%)
USRM Chief Science Officer to Present at Academy of Regenerative Practices Conference

U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, announces our participation in this year's fourth...

USRM : 0.0289 (+2.85%)

Van Meerten Stock Picks

5 Terrific Mid Caps
In this roller coaster market I wanted to find Mid Cap stocks that had consistent price appreciation over the last 6 month period.
EHC +0.24 , FTNT +1.57 , CAKE +0.56 , PLT -0.46 , AEO +0.69
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Agricharts Market Commentary

Today's Commentary

Corn futures are 2 to 3 cents lower this morning. They settled 4 1/4 to 6 cents higher on Turnaround Tuesday. Preliminary open interest showed new buying, up 2489 contracts. A slight decline in crop conditions was supportive, and a stronger USD was i...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar